# Arrowhead Pharmaceuticals, Inc.: Form 8-K, filed Jan 12, 2026

- Company: [Arrowhead Pharmaceuticals, Inc.](/companies/arwr.md) (CIK 879407)
- Form: 8-K
- Filed: 2026-01-12
- Accepted by EDGAR: Jan 12, 2026, 17:00 ET
- Period: 2026-01-12
- Accession: 0001193125-26-010582
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/879407/000119312526010582/d19865d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/879407/000119312526010582/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/879407/000119312526010582/d19865d8k.htm

Filed Jan 12, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-010582. Last ingested by Listed: Nov 13, 2026, 14:55 ET. No prices; not investment advice.